Publication | Closed Access

Raltitrexed (Tomudex®) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)

Gastrointestinal OncologyMedicinePharmacologyClinical TrialsPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchHealth Sciences